Medical Science

Immunology Epidemiology Oncology Vaccinology Vaccines Infectious Diseases Pharmacology Clinical Trials Neuroscience Clinical Research

Ellison Medical Institute Plans 88 Job Cuts in Los Angeles

The WARN filing gives no reason, raising questions about the institute's funding and strategic plans as it continues active research partnerships.

Stories older than 24h

FDA Grants Tentative Approval for First Generic Twice‑Yearly HIV Prevention Injection

CDC Deputy Director Jennifer Shuford to Leave, Last Day Set for Nov. 12

Tovinontrine Shows Target Engagement but Fails to Lower NT‑proBNP at High Dose in Phase II

Influenza Stable in Galicia as Pharmacy Antiviral Dispensing Surges

WHO Seeks Answers From Russia Over Possible Second Death at Irkutsk Plague Institute

Early Flu Activity Prompts Officials to Urge Immediate Vaccination

GE HealthCare to Buy Sofie Biosciences for $945 Million

Peru Honors Medicine Day as Health System Accelerates Digital Upgrades

Alberta Commits $71 Million to Build Calgary Radiopharmaceutical Centre

Transplanted Hearts Adopt Recipients’ Biological Age

Trump Demands Some Childhood Vaccines Be Split Into Five Doses

Regulator-Approved Polilaminina Phase 1 Trial to Start Sept. 24

Stanley Middleman Gives $50 Million to Penn Medicine; Expanded Tower Renamed Middleman Center

World-First Nitinol ‘Super‑Elastic’ Springs Implanted to Treat Infant Skull Fusion

Peripheral Lymph Node Dendritic Cells Drive Tau-Linked Brain Damage in Mice

BioNTech Terminates Phase 2 Colorectal Trial of Autogene Cevumeran as Shares Drop

HHS Opens Public Comment on Rewriting Vaccine Recommendation Categories

States Ramp Up Pledges and Capacity Drives as National Eye Donation Fortnight Starts

Zoo Adapts Human Cancer Therapy to Save 15‑ft Python